8-K Reports
NEUROONE MEDICAL TECHNOLOGIES Corp
CIK

1500198

Accepted

Oct 5, 2026, 01:20 PM

Accession

0001213900-26-106677

2.02 Results of Operations and Financial Condition
8.01 Other Events
9.01 Financial Statements and Exhibits
Items (3)

Item 2.02 Results of Operations and Financial Condition. On October 5, 2026, NeuroOne Medical Technologies Corporation (the “ Company”) issued a press release announcing certain preliminary, unaudited financial results for the fiscal quarter and year ended September 30, 2026. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K (this “ Current Report”) and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit 99.1 attached hereto, shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly stated by specific reference in such a filing.

Item 8.01 Other Events Preliminary Results On October 5, 2026, the Company reported the following preliminary, unaudited fiscal year 2026 financial and operational results: Achieved annual total revenue of approximately $10.5 million for the year ended September 30, 2026. Achieved quarterly revenue of approximately $3.8 million for the quarter ended September 30, 2026. Purchase Order On October 5, 2026, the Company reported receipt during September 2026 of a purchase order for $4.5 million. Approximately $1.0 million of the order shipped by September 30, 2026, with shipments of the remaining $3.6 million expected to begin during the first quarter of fiscal 2027 and into the second quarter of fiscal 2027, subject to manufacturing and delivery schedules.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated October 5, 2026 ─────────────────────────────────────────────────────────────────────────────────────────── 104 Cover Page Interactive Data File (embedded with Inline XBRL document). Forward-Looking Statements

NEUROONE MEDICAL TECHNOLOGIES Corp — 8-K Filing | LevelFields AI